Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-1238

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial ; volume:47 ; number:11 ; day:5 ; month:10 ; year:2021 ; pages:1258-1270 ; date:11.2021
Intensive care medicine ; 47, Heft 11 (5.10.2021), 1258-1270, 11.2021

Creator: Rosas, Ivan O.
Diaz, George
Gottlieb, Robert L.
Lobo, Suzana M.
Robinson, Philip
Hunter, Bradley D.
Cavalcante, Adilson W.
Overcash, J. Scott
Hanania, Nicola A.
Skarbnik, Alan
Garcia-Diaz, Julia
Gordeev, Ivan
Carratalà, Jordi
Gordon, Oliver
Graham, Emily
Lewin-Koh, Nicholas
Tsai, Larry
Tuckwell, Katie
Cao, Huyen
Brainard, Diana
Olsson, Julie K.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00134-021-06507-x

URN: urn:nbn:de:101:1-2022011519251986901335

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rosas, Ivan O.
Diaz, George
Gottlieb, Robert L.
Lobo, Suzana M.
Robinson, Philip
Hunter, Bradley D.
Cavalcante, Adilson W.
Overcash, J. Scott
Hanania, Nicola A.
Skarbnik, Alan
Garcia-Diaz, Julia
Gordeev, Ivan
Carratalà, Jordi
Gordon, Oliver
Graham, Emily
Lewin-Koh, Nicholas
Tsai, Larry
Tuckwell, Katie
Cao, Huyen
Brainard, Diana
Olsson, Julie K.
SpringerLink (Online service)

Other Objects (12)

Factors determining the outcome of children hospitalized with severe pneumonia

Respiratory viruses from hospitalized children with severe pneumonia in the Philippines

Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia

Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports

Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up

Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study

Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia

Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience

A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital

Factors determining the outcome of children hospitalized with severe pneumonia

Respiratory viruses from hospitalized children with severe pneumonia in the Philippines

Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia

Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports

Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up

Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study

Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia

Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience

A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital

Factors determining the outcome of children hospitalized with severe pneumonia

Respiratory viruses from hospitalized children with severe pneumonia in the Philippines

Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia

Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports

Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up

Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study

Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia

Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience

A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Factors determining the outcome of children hospitalized with severe pneumonia

Respiratory viruses from hospitalized children with severe pneumonia in the Philippines

Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia

Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports

Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up

Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study

Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia

Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience

A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital

Factors determining the outcome of children hospitalized with severe pneumonia

Respiratory viruses from hospitalized children with severe pneumonia in the Philippines

Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia

Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports

Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up

Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study

Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia

Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience

A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital

Factors determining the outcome of children hospitalized with severe pneumonia

Respiratory viruses from hospitalized children with severe pneumonia in the Philippines

Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia

Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports

Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up

Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study

Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumonia

Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience

A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital

Related objects

Reset password